Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Merrie Mosedale

5PUBLICATIONS

4CO-AUTHORS

Molecular medicineMolecular targetsTissue engineering

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Nov 04, 2024

Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities.

Sean Hammond, Xiaoli Meng, Jane Barber

|Oct 21, 2020

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury.

Andrew Gibson, Sean Hammond, Kanoot Jaruthamsophon

|Feb 11, 2020

Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury.

Merrie Mosedale, Paul B Watkins

|Jan 03, 2019

Bioprinted liver provides early insight into the role of Kupffer cells in TGF-β1 and methotrexate-induced fibrogenesis.

Leah M Norona, Deborah G Nguyen, David A Gerber

|Jul 27, 2018

Mouse Population-Based Approaches to Investigate Adverse Drug Reactions.

Merrie Mosedale

Pageof 1

Frequent Collaborators

1 joint publications

Leah M Norona

1 joint publications

Dean J Naisbitt

1 joint publications

Sean Hammond

1 joint publications

Paul B Watkins

Frequent Collaborators

1 joint publications

Leah M Norona

1 joint publications

Dean J Naisbitt

1 joint publications

Sean Hammond

1 joint publications

Paul B Watkins

Top Related Videos

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for <em>In Vivo</em> Phenotyping and Drug Monitoring

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for <em>In Vivo</em> Phenotyping and Drug Monitoring

Published on : Jun 23, 2015

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity <em>In Vitro</em>

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity <em>In Vitro</em>

Published on : Jan 31, 2022

See more related videos

Top Related Videos

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for <em>In Vivo</em> Phenotyping and Drug Monitoring

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for <em>In Vivo</em> Phenotyping and Drug Monitoring

Published on : Jun 23, 2015

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity <em>In Vitro</em>

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity <em>In Vitro</em>

Published on : Jan 31, 2022

See more related videos